SCNI · Scinai Immunotherapeutics Ltd. American Depositary Shares
View on chartInsiders & Stakes
| Amir Reichman Chief Executive Officer | ▲ Buy | Grant | 711,637,600 Shares held | 6/16/2026 | View profile |
| Mark Germain Director | ▲ Buy | Grant | 120,000,000 Shares held | 6/16/2026 | View profile |
Transaction History
| Mark Germain | ▲ Buy | Grant | 120,000,000 | $0 | 6/16/2026 |
| Amir Reichman | ▲ Buy | Grant | 400,000,000 | $0 | 6/16/2026 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
SCNI Listed Among Tuesday's Pre-Market Movers
Scinai Immunotherapeutics shares were highlighted in pre-market reports as one of the stocks moving significantly on Tuesday. The company is currently trading well below its 52-week high, reflecting its high-beta nature. These moves are part of broader healthcare sector activity noted in recent market sessions.
SCNI Listed Among Tuesday's Pre-Market Movers. Scinai Immunotherapeutics shares were highlighted in pre-market reports as one of the stocks moving significantly on Tuesday. The company is currently trading well below its 52-week high, reflecting its high-beta nature. These moves are part of broader healthcare sector activity noted in recent market sessions.